Calmare Therapeutics - Delisted Stock
Calmare Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Calmare Therapeutics was actively traded.
Valuation
Check how we calculate scores
Calmare Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Calmare Therapeutics market risk premium is the additional return an investor will receive from holding Calmare Therapeutics long position in a well-diversified portfolio.
| Mean Deviation | 165.8 | |||
| Standard Deviation | 290.29 | |||
| Variance | 84269.17 | |||
| Risk Adjusted Performance | 0.2227 |
Calmare Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calmare Therapeutics stock to make a market-neutral strategy. Peer analysis of Calmare Therapeutics could also be used in its relative valuation, which is a method of valuing Calmare Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Calmare Therapeutics Corporate Management
| Donna Mays | Mang Services | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Stephen DAmato | Chief Medical Officer | Profile | |
| William Lipford | Division Sales | Profile |
Still Interested in Calmare Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Calmare Stock
If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets |